138
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Etiology of Community-Acquired Pneumonia Requiring Hospital Admission in Adults with and Without Cancers: A Single-Center Retrospective Study in China

, , ORCID Icon, , , , & show all
Pages 1607-1617 | Published online: 08 Jun 2020

References

  • World health organization. The top 10 causes of death. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 524, 2018.
  • Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71–79. doi:10.1136/thx.2009.12950220729232
  • Pelton SI, Shea KM, Farkouh RA, et al. Rates of pneumonia among children and adults with chronic medical conditions in Germany. BMC Infect Dis. 2015;15:470. doi:10.1186/s12879-015-1162-y26515134
  • Hicks BM, Yin H, Bladou F, Ernst P, Azoulay L. Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia. Thorax. 2017;72(7):596–597. doi:10.1136/thoraxjnl-2016-209512
  • Schmedt N, Heuer OD, Häckl D, Sato R, Theilacker C. Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer. BMC Health Serv Res. 2019;19(1):30. doi:10.1186/s12913-018-3861-830642312
  • Rolston K, Nesher L. Post-obstructive pneumonia in patients with cancer: a review. Infect Dis Ther. 2018;7(1):29–38. doi:10.1007/s40121-018-0185-229392577
  • Nie XM, Li YS, Yang ZW, et al. Initial empiric antibiotic therapy for community-acquired pneumonia in Chinese hospitals. Clin Microbiol Infect. 2018;24(6):658.e1–658.e6. doi:10.1016/j.cmi.2017.09.014
  • Shinohara S, Sugaya M, Onitsuka T, Machida K, Matsuo M, Tanaka F. Impact of postoperative pneumonia developing after discharge on long-term follow-up for resected lung cancer. World J Surg. 2018;42(12):3979–3987. doi:10.1007/s00268-018-4727-229946786
  • Gowing SD, Chow SC, Cools-Lartigue JJ, et al. Gram-negative pneumonia augments non-small cell lung cancer metastasis through host toll-like receptor 4 activation. J Thorac Oncol. 2019;14(12):2097–2108. doi:10.1016/j.jtho.2019.07.02331382038
  • Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med. 2014;371(17):1619–1628. doi:10.1056/NEJMra131288525337751
  • Gajdács M, Urbán E. Epidemiological trends and resistance associated with stenotrophomonas maltophilia bacteremia: a 10-year retrospective cohort study in a tertiary-care hospital in hungary. Diseases. 2019;7:2. doi:10.3390/diseases7020041
  • Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest. 2008;133(3):610–617. doi:10.1378/chest.07-145617989157
  • Cillóniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66(4):340–346. doi:10.1136/thx.2010.14398221257985
  • Gajdács M, Urbán E. Prevalence and antibiotic resistance of stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot. Health Serv Res Manag Epidemiol. 2019;6:2333392819870774. doi:10.1177/233339281987077431453265
  • Cao B, Huang Y, She DY, et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese thoracic society, Chinese medical association. Clin Respir J. 2018;12(4):1320–1360. doi:10.1111/crj.1267428756639
  • Zhu YG, Tang XD, Lu YT, Zhang J, Qu JM. Contemporary situation of community-acquired pneumonia in China: a systematic review. J Transl Int Med. 2018;6(1):26–31. doi:10.2478/jtim-2018-000629607301
  • Wang S, Xu J, Jiang X, et al. Trends in health resource disparities in primary health care institutions in Liaoning Province in Northeast China. Int J Equity Health. 2018;17(1):178. doi:10.1186/s12939-018-0896-830514300
  • The State Council of the People’s Republic of China. The 13th five-year plan for deepening reform of the medical and health care systems, Beijing 2017. Available from: http://www.gov.cn/zhengce/content/2017-01/09/content_5158053.htm.
  • Dowell SF, Whitney CG, Wright C, Rose CE Jr, Schuchat A. Seasonal patterns of invasive pneumococcal disease. Emerg Infect Dis. 2003;9(5):573–579. doi:10.3201/eid0905.02055612737741
  • Rubach MP, Bender JM, Mottice S, et al. Increasing incidence of invasive haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis. 2011;17(9):1645–1650. doi:10.3201/eid1709.10199121888789
  • Abers MS, Sandvall BP, Sampath R, et al. Postobstructive pneumonia: an underdescribed syndrome. Clin Infect Dis. 2016;62(8):957–961. doi:10.1093/cid/civ121226908806
  • Urbaniak A, Zięba M, Zwolińska A, et al. Comparison of local and systemic inflammatory markers in patients with community-acquired pneumonia and pneumonia coexisting with lung cancer. Pneumonol Alergol Pol. 2011;79(2):90–98.21351059
  • José R, Mohammed AO, Goldring J, Chambers RC, Brown JS, Agarwal B. Cancer patients with community-acquired pneumonia treated in intensive care have poorer outcomes associated with increased illness severity and septic shock at admission to intensive care: a retrospective cohort study. Pneumonia (Nathan). 2015;6:77–82. doi:10.15172/pneu.2015.6/64531641581
  • Madenspacher JH, Azzam KM, Gowdy KM, et al. p53 Integrates host defense and cell fate during bacterial pneumonia. J Exp Med. 2013;210(5):891–904. doi:10.1084/jem.2012167423630228
  • Gajdács M. The continuing threat of methicillin-resistant Staphylococcus aureus. Antibiotics (Basel). 2019;8:2. doi:10.3390/antibiotics8020052
  • Vardakas KZ, Matthaiou DK, Falagas ME. Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia. Eur Respir J. 2009;34(5):1148–1158. doi:10.1183/09031936.0004100919541719
  • Dunaway S, Orwig KW, Arbogast ZQ, Myers ZL, Sizemore JA, Giancola SE. Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia. Int J Clin Pharm. 2018;40(3):526–532. doi:10.1007/s11096-018-0647-329721739
  • Shindo Y, Ito R, Kobayashi D, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2013;188(8):985–995. doi:10.1164/rccm.201301-0079OC23855620
  • Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med. 2019;200(7):e45–45e67. doi:10.1164/rccm.201908-1581ST31573350
  • Chen C, Zhao Q, Guo J, Li Y, Chen Q. Identification of Methicillin-Resistant Staphylococcus aureus (MRSA) using simultaneous detection of mecA, nuc, and femB by Loop-Mediated Isothermal Amplification (LAMP). Curr Microbiol. 2017;74(8):965–971. doi:10.1007/s00284-017-1274-228573341
  • Becker K, Denis O, Roisin S, et al. Detection of mecA- and mecC-positive Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates by the new Xpert MRSA Gen 3 PCR assay. J Clin Microbiol. 2016;54(1):180–184. doi:10.1128/JCM.02081-1526491186